Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, 54, Shogoin-kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Gastric Cancer. 2019 Jul;22(4):892-898. doi: 10.1007/s10120-018-00912-w. Epub 2018 Dec 12.
Germline mutations in CDH1, encoding E-cadherin, are known to be the causative mechanism of hereditary diffuse gastric cancer (HDGC). We encountered two cases of gastric cancer in a Japanese family with HDGC. A 28-year-old man (Case 1) died of advanced gastric cancer. His younger sister aged 27 (Case 2) was diagnosed with intramucosal signet ring cell carcinoma (SRCC). Both had identical germline CDH1 mutations, but Case 1 was positive for Helicobacter pylori infection, whereas Case 2 was negative. Case 2 underwent total gastrectomy. Whole-exome sequencing of an intramucosal SRCC in Case 2 revealed seven somatic mutations including one in CDH1. The six non-CDH1 mutations were classified as non-driver mutations. Decreased expression of E-cadherin in intramucosal SRCC was confirmed by immunohistochemistry. Our report demonstrated that CDH1 mutation was the only active driver mutation in Helicobacter pylori-uninfected intramucosal SRCC.
胚系 CDH1 基因突变是遗传性弥漫性胃癌(HDGC)的致病机制。我们在一个有 HDGC 病史的日本家族中遇到了两例胃癌病例。一名 28 岁男性(病例 1)死于晚期胃癌。他 27 岁的妹妹(病例 2)被诊断为黏膜内印戒细胞癌(SRCC)。两人均携带相同的胚系 CDH1 突变,但病例 1 幽门螺杆菌感染阳性,而病例 2 为阴性。病例 2 接受了全胃切除术。对病例 2 的黏膜内 SRCC 进行全外显子组测序显示存在 7 个体细胞突变,其中包括一个 CDH1 突变。这 6 个非 CDH1 突变被归类为非驱动突变。免疫组织化学证实黏膜内 SRCC 中 E-钙黏蛋白表达减少。我们的报告表明,CDH1 突变是幽门螺杆菌阴性黏膜内 SRCC 中唯一的活跃驱动突变。
Gastric Cancer. 2014-10
Ann Surg Oncol. 2011-3-18
Gastrointest Endosc. 2017-7-6
Intern Med. 2024-1-15
Histol Histopathol. 2023-9
World J Gastrointest Oncol. 2019-7-15
JAMA Oncol. 2015-4